Am I correctly interpreting Muzza's comment - is he suggesting that the FDA sought more information and delayed the finalisation of the P3 endpoints because they thought our program would be eligible for BTD and pushed us to supply more/additional information?
Ann: Update - Notification of buy-back - NEU, page-94
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.613B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.92 | $2.373M | 180.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 271 | $12.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.97 | 356 | 10 |
View Market Depth
| Last trade - 12.43pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |